VOGLISTAR PLUS 0.2MG (Metformin (500mg) + Voglibose (0.2mg))

Voglistar-Plus 0.2 mg is classified among anti-diabetic medications and is specifically designed for adults dealing with type 2 diabetes mellitus. This combination product assists in managing blood glucose levels effectively in individuals diagnosed with diabetes. It is important to take Voglistar-Plus 0.2 mg alongside food to enhance its efficacy. For optimal results, it is recommended to administer the tablet consistently at the same time each day. The appropriate dosage will be determined by your physician, who may adjust it based on your blood sugar readings and overall response to the treatment. It is crucial to continue the medication as prescribed, even when you feel fine or your blood glucose appears stable. Discontinuing this medication without medical advice could lead to elevated blood sugar levels, which increases the risk of serious complications such as kidney damage, vision loss, nerve impairment, and possible limb amputation. This medication should be part of a comprehensive management plan that includes a balanced diet, regular physical activity, and weight management as directed by your healthcare provider. Lifestyle modifications are fundamental in the effective management of diabetes. While taking this medication, some individuals may experience transient side effects, including nausea, altered taste, reduced appetite, gas, abdominal discomfort, diarrhea, and skin rashes. Typically, these symptoms are temporary and resolve on their own. However, if they persist or cause concern, it is advisable to consult your doctor for further guidance. Voglistar-Plus is contraindicated in individuals with type 1 diabetes, diabetic ketoacidosis, or severe renal or hepatic impairment. Prior to initiation of therapy, it is essential to inform your healthcare provider about any history of cardiovascular conditions, as this may influence suitability for treatment. Pregnant or nursing individuals should also seek medical advice before using this drug. Regular monitoring of blood glucose levels, as well as periodic blood tests to evaluate blood cell counts and liver function, may be recommended by your healthcare professional during the course of treatment.